Yuxin Huang , Tafesse Adigawe , Siyuan Tang , Mei Sun
{"title":"Antipsychotic medication non-adherence and its associated factors among patients with schizophrenia in Ethiopia: A cross-sectional study","authors":"Yuxin Huang , Tafesse Adigawe , Siyuan Tang , Mei Sun","doi":"10.1016/j.apnu.2025.151939","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to assess antipsychotic medication non-adherence among patients with schizophrenia in Ethiopia, and to explore its associated factors based on the Multidimensional Adherence Model.</div></div><div><h3>Methods</h3><div>This study is a cross-sectional study using convenience sampling enrolled 406 schizophrenia patients from July 17 to August 25, 2023. Data collection included medication non-adherence, sociodemographic factors, patient-related factors, therapy-related factors, condition-related factors, and healthcare system-related factors. Medication non-adherence was measured via the Morisky Medication Adherence Scale. Social support was assessed using the Oslo-3 social support scale (OSSS-3), and medication attitudes were measured via the drug attitude inventory-10 (DAI-10). Logistic regression analyzed associations between these factors and medication non-adherence.</div></div><div><h3>Results</h3><div>The antipsychotic medication non-adherence rate among Ethiopian schizophrenia patients was 42.4 %, with significant associated factors including no formal education (AOR = 3.093, 95 %CI: 1.426–6.709, <em>P</em> = 0.004), impaired insight (poor insight: AOR = 3.151, 95 %CI: 1.765–5.624, <em>P</em> < 0.001; partial insight: AOR = 4.309, 95 %CI: 2.463–7.539, <em>P</em> < 0.001), perceived stigma because of schizophrenia (AOR = 1.904, 95 %CI: 1.201–3.016, <em>P</em> = 0.006), polypharmacy (AOR = 2.133, 95 %CI: 1.339–3.396, <em>P</em> = 0.001), disease duration <5 years (AOR = 2.313, 95 %CI: 1.361–3.932, <em>P</em> = 0.002), and current substance use (AOR = 2.007, 95 %CI: 1.266–3.181, <em>P</em> = 0.003).</div></div><div><h3>Conclusion</h3><div>In this research, the antipsychotic medication non-adherence was relatively high, and seven significant associated factors were identified. Future research should target these factors to develop more effective strategies to improve antipsychotic medication adherence among patients with schizophrenia in Ethiopia.</div></div>","PeriodicalId":55466,"journal":{"name":"Archives of Psychiatric Nursing","volume":"58 ","pages":"Article 151939"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Psychiatric Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0883941725001104","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
This study aimed to assess antipsychotic medication non-adherence among patients with schizophrenia in Ethiopia, and to explore its associated factors based on the Multidimensional Adherence Model.
Methods
This study is a cross-sectional study using convenience sampling enrolled 406 schizophrenia patients from July 17 to August 25, 2023. Data collection included medication non-adherence, sociodemographic factors, patient-related factors, therapy-related factors, condition-related factors, and healthcare system-related factors. Medication non-adherence was measured via the Morisky Medication Adherence Scale. Social support was assessed using the Oslo-3 social support scale (OSSS-3), and medication attitudes were measured via the drug attitude inventory-10 (DAI-10). Logistic regression analyzed associations between these factors and medication non-adherence.
Results
The antipsychotic medication non-adherence rate among Ethiopian schizophrenia patients was 42.4 %, with significant associated factors including no formal education (AOR = 3.093, 95 %CI: 1.426–6.709, P = 0.004), impaired insight (poor insight: AOR = 3.151, 95 %CI: 1.765–5.624, P < 0.001; partial insight: AOR = 4.309, 95 %CI: 2.463–7.539, P < 0.001), perceived stigma because of schizophrenia (AOR = 1.904, 95 %CI: 1.201–3.016, P = 0.006), polypharmacy (AOR = 2.133, 95 %CI: 1.339–3.396, P = 0.001), disease duration <5 years (AOR = 2.313, 95 %CI: 1.361–3.932, P = 0.002), and current substance use (AOR = 2.007, 95 %CI: 1.266–3.181, P = 0.003).
Conclusion
In this research, the antipsychotic medication non-adherence was relatively high, and seven significant associated factors were identified. Future research should target these factors to develop more effective strategies to improve antipsychotic medication adherence among patients with schizophrenia in Ethiopia.
期刊介绍:
Archives of Psychiatric Nursing disseminates original, peer-reviewed research that is of interest to psychiatric and mental health care nurses. The field is considered in its broadest perspective, including theory, practice and research applications related to all ages, special populations, settings, and interdisciplinary collaborations in both the public and private sectors. Through critical study, expositions, and review of practice, Archives of Psychiatric Nursing is a medium for clinical scholarship to provide theoretical linkages among diverse areas of practice.